Tomatidine Is a Lead Antibiotic Molecule That Targets Staphylococcus aureus ATP Synthase Subunit C
Authors:
- 1 June 2018
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 62 (6) , e02197-17
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of deadly hospital-acquired infections. The discovery of anti- Staphylococcus antibiotics and new classes of drugs not susceptible to the mechanisms of resistance shared among bacteria is imperative. We recently showed that tomatidine (TO), a steroidal alkaloid from solanaceous plants, possesses potent antibacterial activity against S. aureus small-colony variants (SCVs), the notoriously persistent form of this bacterium that has been associated with recurrence of infections. Here, using genomic analysis of in vitro -generated TO-resistant S. aureus strains to identify mutations in genes involved in resistance, we identified the bacterial ATP synthase as the cellular target. Sequence alignments were performed to highlight the modified sequences, and the structural consequences of the mutations were evaluated in structural models. Overexpression of the atpE gene in S. aureus SCVs or introducing the mutation found in the atpE gene of one of the high-level TO-resistant S. aureus mutants into the Bacillus subtilis atpE gene provided resistance to TO and further validated the identity of the cellular target. FC04-100, a TO derivative which also possesses activity against non-SCV strains, prevents high-level resistance development in prototypic strains and limits the level of resistance observed in SCVs. An ATP synthesis assay allowed the observation of a correlation between antibiotic potency and ATP synthase inhibition. The selectivity index (inhibition of ATP production by mitochondria versus that of bacterial ATP synthase) is estimated to be >10 5 -fold for FC04-100.Keywords
Funding Information
- Cystic Fibrosis Canada
- Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada
- Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (2015-05916)
- Fonds de recherche du Québec-Nature et technologies
- Fonds de recherche du Québec-Nature et technologies
This publication has 77 references indexed in Scilit:
- Bedaquiline: First FDA-approved tuberculosis drug in 40 yearsInternational Journal of Applied & Basic Medical Research, 2013
- The antibiotic resistance “mobilome”: searching for the link between environment and clinicFrontiers in Microbiology, 2013
- Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive studyThe Lancet Infectious Diseases, 2011
- Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infectionEMBO Molecular Medicine, 2011
- Targeting bacterial membrane function: an underexploited mechanism for treating persistent infectionsNature Reviews Microbiology, 2010
- ABACAS: algorithm-based automatic contiguation of assembled sequencesBioinformatics, 2009
- Phylogenomics of Sterol Synthesis: Insights into the Origin, Evolution, and Diversity of a Key Eukaryotic FeatureGenome Biology and Evolution, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infectionsNature Reviews Microbiology, 2006
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997